Cite

HARVARD Citation

    Kronthaler, U. et al. (2014). AB0412 Preclinical PK and Safety Assessment of the Proposed Adalimumab Biosimilar Gp2017, Compared to Humira®. Annals of the rheumatic diseases. p. 943. [Online]. 
  
Back to record